GLP-1 receptor agonists were originally developed for type 2 diabetes before their weight loss effects were fully appreciated. They remain a cornerstone of diabetes management — and understanding how they work helps you use them more effectively.
Because GLP-1's insulin-stimulating effect is glucose-dependent, the risk of hypoglycaemia (dangerous low blood sugar) is much lower than with insulin or sulfonylureas. This makes GLP-1 agonists particularly attractive for people managing diabetes independently.
Clinical trials show GLP-1 agonists typically reduce HbA1c by 1–2 percentage points. Combined with weight loss, some people with type 2 diabetes achieve remission — normal blood sugars without medication. This is a real possibility, not just theoretical.
GLP-1 agonists are commonly combined with metformin, SGLT-2 inhibitors (like empagliflozin), and sometimes insulin. Your doctor will adjust your regimen as your blood sugar improves — often reducing or eliminating other medications over time.
Getting 100g+ of protein daily on a reduced appetite is hard. Strategic timing makes it more achievable — and more effective for muscle preservation.
Medication helps with appetite. But the mental skills for sustainable weight management — resilience, flexibility, self-compassion — must be built intentionally.
People who share their journey with a community — online or in person — consistently achieve better outcomes. Here's why, and where to find yours.